| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
|---|
| Outline of Final Research Achievements |
We investigated barriers to cervical screening and whether HPV self-sampling(SS) might improve screening uptake in non-responders. In adjusted analyses: not in relationship (OR 3.40, 95% CI 1.52-7.59), lower education (OR 1.88, 95% CI 1.04-3.39), smoking (OR 4.06, 95% CI 1.61-10.26), and no perceived risk (OR 3.79, 95% CI 1.43-10.07) were predictors of screening status in under-screened women. For never-screened, it was smoking (OR 5.15, 95% CI 1.93-13.76) and no perceived risk (OR 3.17, 95% CI 1.10-9.14). Common barriers such as 'embarrassment’ and ‘too busy with work/childcare’ were also endorsed by women up-to-date for screening and not predictive of screening status. SS acceptability was high with >90% saying they would use it again and recommend it to friends/family. In the RCT compared to the control, screening uptake in the SS group was significantly higher (RR 8.31, 95% CI:6.68-10.34). SS might be an effective means of improving screening uptake in Japanese women.
|
